Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,074 | -3,085 | -1,742 | -2,845 | -3,659 |
| Depreciation Amortization | 6 | 1,049 | 811 | 507 | 296 |
| Other Working Capital | 486 | 354 | 126 | 74 | -39 |
| Other Operating Activity | 168 | 146 | 151 | 135 | 192 |
| Operating Cash Flow | $-1,414 | $-1,537 | $-654 | $-2,129 | $-3,210 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -4 | N/A |
| PPE Investments | N/A | N/A | N/A | N/A | -5 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-4 | $-5 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 600 | N/A | N/A | N/A | 3,350 |
| Debt Repayment | -130 | -1,850 | N/A | N/A | N/A |
| Common Stock Issued | 1,787 | 4,203 | 87 | 2,075 | 199 |
| Other Financing Activity | -380 | -162 | 0 | -310 | 0 |
| Financing Cash Flow | $1,877 | $2,190 | $87 | $1,765 | $3,549 |
| Beginning Cash Position | 1,371 | 717 | 1,284 | 1,653 | 1,318 |
| End Cash Position | 1,834 | 1,371 | 717 | 1,284 | 1,653 |
| Net Cash Flow | $463 | $654 | $-567 | $-368 | $334 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,414 | -1,537 | -654 | -2,129 | -3,210 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -5 |
| Free Cash Flow | -1,414 | -1,537 | -654 | -2,129 | -3,215 |